Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
Video game training enhances cognitive control in older adults.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Emerging roles of exosomes in neuron-glia communication.
Cannabinoid pharmacology: the first 66 years.
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Neurorehabilitation for other neurologic disorders.
Breastfeeding is associated with lower risk for multiple sclerosis.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Transverse myelitis.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.

Pages